Indications for Use
BrainScope Academy
Technology
Science & Technology
Product Support
Patients
Clinicians
Emergency Departments
Concussion
Military
About Us
Resources
Blog
Publications
News & Releases
Videos
User Manuals
Indications for Use
BrainScope Academy
Get A Demo
Publications & Media >
All Press Releases
Press Releases
2023
BrainScope receives investment from the Alzheimer's Drug Discovery Foundation for Alzheimer's Prediction Biomarker
2022
Tri-anim Health Services Announces Exclusive Relationship to Distribute BrainScope's Breakthrough Technology for Mild Head Injury Including Concussion
BrainScope Receives Innovative Technology Contract from Vizient for Its Novel Head Injury Triage Medical Device
BrainScope Named “Best New Diagnostic Technology Solution” in 2022 MedTech Breakthrough Awards Program
Prominent Emergency Medicine Expert Diku Mandavia, MD Joins BrainScope as Chief Medical Officer
2021
Adventist Health hospitals only facilities on the West Coast to offer new technology to assess for brain injuries – including concussions
BrainScope Completes Agreement with 18,000 Member Yankee Alliance
BrainScope and Aon Secure IP-based Deal Funding Full Expansion of Commercial Activities and Pursuit of New Indications for BrainScope’s Next-Gen Medical Device Platform
BrainScope Launches Next-Gen Medical Device: First and only FDA-cleared system for true point-of-care assessment of both concussion and brain bleeds now includes Concussion Index
JAMA Highlights Success of BrainScope's EEG-based Concussion Index As Reliable Indicator of Concussion
2020
BrainScope Wins BioHealth Capital Region 5th Annual Crab Trap Competition
2019
BrainScope Surpasses Primary Endpoints in Multi-Year Department of Defense-Funded Validation Study for New Concussion Assessment Capability
BrainScope Advances its Commercial Adoption and Appoints Industry Veteran Susan Hertzberg as CEO
Over 30% Reduction in Unnecessary Head CT Scans When Integrating FDA-Cleared BrainScope One
BrainScope Completes Large-Scale Clinical Studies of Concussion in Universities, High Schools and Concussion Clinics
BrainScope Announces Publication Describing Proprietary Concussion Biomarker to Assess Potential Severity and Predict Prolonged Recovery
BrainScope Receives FDA Clearance for Multi-Modal, Multi-Parameter Concussion Assessment
2018
Ron Klain Joins BrainScope Board of Directors
BrainScope Honors Veterans Day and Supports U.S. Army Deployment of Traumatic Brain Injury (TBI) and Concussion Assessment Devices
BrainScope Receives $4.5 Million Department of Defense Contract to Add Ocular Assessment to Future Concussion Products
BrainScope Receives Prix Galien Award Nomination for Its Concussion and Traumatic Brain Injury Assessment Product
Over 30% Potential Cost Reduction to Payers and Patients through Integration of BrainScope One for Mild Traumatic Brain Injury / Concussion Assessment
BrainScope Initiates Teenage and Young Adult Multi-Site Clinical Study for Concussion Assessment Product
Using BrainScope One in Urgent Care Centers Shows Potential 75% Reduction in Head Injury Referrals to Emergency Departments
BrainScope One Demonstrated the Potential to Reduce Head CT Scans By One-Third in Emergency Department Use
2017
BrainScope Initiates Development of Pediatric Product for Objective Assessment of Traumatic Brain Injury, Including Concussion
BrainScope Completes $16 Million Equity Fundraise
BrainScope Receives Frost & Sullivan Best Practices Award in Traumatic Brain Injury Assessment
Strong Utility of BrainScope’s Brain Function Index for Head Injury Assessment Demonstrated in Validation Trial
One-Third Potential Reduction in Unnecessary Head CT Scans Demonstrated in BrainScope One Study
Multi-Year Study Using BrainScope's Brain Function Index Suggests Compelling Utility as an Objective Biomarker for Concussion
BrainScope One Revolutionizes Brain Injury Assessment for Urgent Care Clinics
BrainScope Biomarker Adds Significant Prognostic Accuracy for Rapid Assessment of Traumatic Brain Injury
BrainScope Announces Publication Demonstrating Extremely High Accuracy of the Ahead 300 for Identification of Traumatic Brain Injury in a Large Prospective Validation Study
BrainScope Launches the Ahead 300 for Objective Assessment of Mild Head Injury, Including Concussion
2016
BrainScope Announces FDA Clearance of the First Handheld Medical Device for Assessment of the Full Spectrum of Traumatic Brain Injury
BrainScope Awarded Maryland Emerging Life Science Business of the Year
BrainScope’s Objective Concussion Assessment Technology Showcased at NFL Annual Meeting
2015
BrainScope to Present at the 27th Annual Piper Jaffray Healthcare Conference
GE and the NFL Award BrainScope with Further Funding
BrainScope's Ahead 200 Device Cleared by FDA for Adjunctive Assessment of Traumatic Brain Injury
BrainScope Announces Publication Demonstrating High Accuracy For Identification of Acute Stroke
2014
BrainScope Announces FDA Clearance of Ahead 100 Device for Adjunctive Assessment of Traumatic Brain Injury
BrainScope Collects $15.9M From Military for Traumatic Brain Injury Detection
BrainScope Awarded over $15.9 Million in Department of Defense Research Contracts
BrainScope Announces Publication of Independent, Prospective Validation Study Demonstrating High Accuracy For Identification of Traumatic Intracranial Hematomas
BrainScope Receives ISO 13485 Certification
BrainScope Receives GE NFL Head Health Challenge I Award
2012
BrainScope Awarded Montgomery County Emerging Business of the Year
BrainScope® Awarded $2.67 Million / U.S. Army Rapid Innovation Fund Research Contract
BrainScope Announces Publication of Findings From Three Years of Concussion Studies in Football Players
BrainScope Strengthens Executive Leadership Team
2011
Maryland Venture Fund Makes Initial Investment in BrainScope® to Help Develop Device to Assess Traumatic Brain Injury / Concussion
BrainScope Awarded $7.5 Million Department of Defense Research Contract for Assessment of Traumatic Brain Injury
BrainScope Announces Concurrence with FDA on Study Design for Its Traumatic Brain Injury Assessment Device
2010
BrainScope Announces Findings of Traumatic Brain Injury Study in the Emergency Department
BrainScope Announces Release of Concussion Findings in High School and College Football Players
2009
Gail Wilensky, Ph.D. Joins BrainScope Board of Directors
BrainScope Receives FDA Clearance for Portable EEG Device
The Honorable James Peake, M.D. Joins BrainScope's Board of Directors
BrainScope Positioned to Identify Traumatic Brain Injuries Suffered by Military Troops
2008
BrainScope Company, Inc. Announces New Investment and Leadership to Fuel Growth